Document is current
Any future updates will be listed below
-
Authors
Zhang, Bo
Shi, Xuetao
Cui, Kai
Li, Zhongchao
Li, Lei
Liu, Zhaogang
Zhang, Chengsheng
Sun, Pengfei
Zhong, Jingtao
Sun, Zhicheng
Chang, Zhibin
Ma, Zhao
Gordon-Weeks, Alex
Li, Mingming
Zhao, Lei
-
Funding
Funding for this research was provided by:
the Key Research and Development Program of Shandong (2021SFGC0501)
- License Information
-
More Information
Article History
Received: 10 December 2022
Accepted: 12 May 2023
First Online: 20 May 2023
Declarations
:
: All research in this study was conducted in accordance with both the Declarations of Helsinki and Istanbul. The study was approved by the Ethics Committee of Shandong Cancer Hospital Affiliated to Shandong First Medical University, with waiver of informed consent. There are three reasons. First, the period of this study is long. Second, no patient privacy information is involved. Third, this is a retrospective study, it did not intervene the decisions of the treatments.
: Not applicable. All information and images in the manuscript have been anonymized and will not lead to identification of the study participants.
: LZ is on the speakers’ bureau for BeiGene, Bayer, MSD, Roche, Innovent, and Hengrui Medicine. Other authors declare no COI.
